Torrent Pharmaceuticals Ltd. NSE: TORNTPHARM | BSE: 500420

Expensive Performer

Download real time

3561.00 29.40 (0.83%)

726.9K

NSE+BSE Volume

High volume today

NSE 26 Sep, 2025 3:31 PM (IST)

Regulatory Approval

Torrent Pharma gets approval from South Africa's Competition Commission to acquire JB Chemicals See details

Torrent Pharmaceuticals Ltd. share price target

Torrent Pharmaceuticals Ltd. has an average share price target of 3746. The consensus estimate represents an upside of 5.20% from the last price of 3561. View 11 reports from 5 analysts offering long-term price targets for Torrent Pharmaceuticals Ltd..

Reco - This broker has downgraded this stock from it's previous report.
(eg. - Buy->Hold)

Target - Broker has maintained previous recommendation but reduced share price target.

Reco - This broker has upgraded this stock from it's previous report.
(eg. - Sell->Hold)

Target - Broker has maintained previous recommendation but increased share price target.

Load latest Google or static link led you to an intermediate page.

Click on any table column to sort reports by date, stock name, broker, price, target, upside or recommendation.

Summary	Date	Stock	Author	LTP	Target	Price at reco (Change since reco%)	Upside(%)	Type	Report		Discuss
	26 Sep 2025	Torrent Pharma	Consensus Share Price Target	3561.00	3929.42	-	10.35	buy	pdf Detailed Estimates
	31 May 2023	Torrent Pharma	ICICI Direct Reco Target	3561.00	2010.00	1835.80 (93.98%)	Target met	Buy	pdf post cache		Broker Report Torrent Pharmaceuticals ICICI Direct pdf Copy Link Share on Share on Share on Share on Alert
	31 May 2023	Torrent Pharma	Prabhudas Lilladhar Target	3561.00	1900.00	1835.80 (93.98%)	Target met	Buy	pdf post cache		Broker Report TORRENT PHARMACEUTIC Prabhudas Lilladhar pdf Copy Link Share on Share on Share on Share on Alert
	17 Mar 2023	Torrent Pharma	Sharekhan Target	3561.00	1788.00	1534.00 (132.14%)	Target met	Buy	pdf post cache		Broker Report Torrent Pharma Sharekhan pdf Copy Link Share on Share on Share on Share on Alert
	27 Jan 2023	Torrent Pharma	ICICI Securities Limited	3561.00	1853.00	1556.75 (128.75%)	Target met	Buy	pdf post cache		Broker Report Branded business outperforms ICICI Securities Limited Torrent Pharma’s (Torrent) Q3FY23 performance beats our estimates on all parameters. Revenue grew 18.3% YoY to Rs24.9bn (I-Sec: Rs23.3bn) led by 17.4% growth in India and 35.5% growth in Brazil. pdf Copy Link Share on Share on Share on Share on Alert
	27 Jan 2023	Torrent Pharma	ICICI Direct Target	3561.00	1720.00	1537.40 (131.62%)	Target met	Hold	pdf post cache		Broker Report Torrent Pharmaceuticals ICICI Direct pdf Copy Link Share on Share on Share on Share on Alert
	03 Nov 2022	Torrent Pharma	Geojit BNP Paribas	3561.00	1819.00	1666.90 (113.63%)	Target met	Hold	pdf post cache		Broker Report TORRENT PHARMA Geojit BNP Paribas pdf Copy Link Share on Share on Share on Share on Alert
	25 Oct 2022	Torrent Pharma	Prabhudas Lilladhar	3561.00	1850.00	1599.65 (122.61%)	Target met	Buy	pdf post cache		Broker Report TORRENT PHARMACEUTIC Prabhudas Lilladhar pdf Copy Link Share on Share on Share on Share on Alert
	25 Oct 2022	Torrent Pharma	ICICI Securities Limited Target	3561.00	1853.00	1567.30 (127.21%)	Target met	Buy	pdf post cache		Broker Report Branded business continues to grow ICICI Securities Limited Torrent Pharma’s (Torrent) Q2FY23 performance was broadly in line with our estimates with revenue growing 7.2% YoY to Rs22.9bn and EBITDA margin at 29.6% (I-Sec: 30%). India grew 12.6% YoY while Brazil grew 18.6% YoY. pdf Copy Link Share on Share on Share on Share on Alert
	22 Oct 2022	Torrent Pharma	ICICI Direct Reco Target	3561.00	1690.00	1573.60 (126.30%)	Target met	Hold	pdf post cache		Broker Report Torrent Pharmaceuticals ICICI Direct pdf Copy Link Share on Share on Share on Share on Alert
	29 Sep 2022	Torrent Pharma	ICICI Securities Limited	3561.00	1769.00	1494.30 (138.31%)	Target met	Buy	pdf post cache		Broker Report Torrent acquires derma player Curatio ICICI Securities Limited Torrent Pharma (Torrent) is acquiring Curatio Healthcare Private Limited for a purchase consideration of Rs20bn. pdf Copy Link Share on Share on Share on Share on Alert
more loading

* Please note that subscribers can download a maximum of 300 reports a month and 70 reports everyday.

Advisor Screeners